FIFTY CLINIC BUILDOUTS. ONE AGREEMENT. ZERO PERCENT OF REVENUE.
The Atlas Master License delivers fifty complete, branded metabolic-wellness clinic businesses on one written specification, under one agreement, for one one-time fee — with 0% of revenue at the site level and the platform level. Each site owns its brand, site, patient list, and equity; the platform owns the consolidated commercial assets.
Terms are set out in the master agreement and its schedules. Bring counsel.
- $33.8BU.S. metabolic marketMarketdata, 2025
- 1 in 8U.S. adults have used a GLP-1 medicationKFF, 2024
- 28 · 8Deliverables · workstreams — per site, acceptance-testedBuild Specification
- 0%Of revenue — no royalty, no ad fund, no ongoing Atlas feesAt the site level and the platform level
One agreement. Fifty sites. Terms in outline.
The commercial terms below are the terms. The derived math, the payment schedule, and the delivery schedule are walked through in the term sheet review, against the master agreement draft.
- Master license fee
- $1,500,000 one-time
- Scope
- Fifty (50) clinic buildouts, delivered site by site
- Per-site deliverable
- The written Build Specification — 28 deliverables across 8 workstreams, each with a written acceptance test signed per site
- Ongoing economics
- 0% of revenue; no royalty, ad fund, or ongoing Atlas fees at any level
- Ownership
- Brand, site, patient list, and equity vest per operating entity; consolidated commercial assets vest in the platform
- Delivery cadence & market allocation
- By written schedule in the master agreement
- Clinical boundary
- Separately licensed medical entities own all clinical care; Atlas provides no medical services and employs no clinicians
- Reserve & payment
- Per the master agreement (wire)
These are the only figures on this page. Per-site derivations and the tranche schedule are covered in the two-page term summary and the term sheet review, as documents.
Eight workstreams. Twenty-eight deliverables. Per site.
The same written specification for site one and site fifty. Each workstream closes on a signed acceptance test.
- 01
Brand & positioning
Name, identity system, and market positioning delivered as a complete brand kit for the site.
- 02
Conversion website & funnels
A live site and the enrollment funnels behind it, generated from the site's brand kit.
- 03
CRM & follow-up automation
Pipeline stages, follow-up cadences, and reporting configured and documented for the site team.
- 04
12-week program & member journey
The structured program and member experience, from enrollment to completion, documented end to end.
- 05
Non-prescription supplement supply (COA-documented)
A documented supply line for the non-prescription supplement range, with certificates of analysis on file.
- 06
Team hiring & training
Role descriptions, hiring guides, and training curricula for the site's operating team.
- 07
Local patient acquisition
Local campaign structure, creative, and reporting for the site's own market.
- 08
Compliance scope & operations library (233 files)
The written compliance scope for the commercial business and the 233-file operations library, per site.
Built for the fifty, not the one.
Three mechanisms sit above the site-level specification. Each is written into the master agreement.
- Replication at scale
Brand kit in, live site out.
Each site's brand kit becomes a live site through a structured intake — no bespoke agency cycle between sites, and no drift from the specification.
- Consolidated reporting
Site dashboards roll up to the platform.
Leads, appointments, show rate, enrollment, retention, and contribution margin — operating metrics reported per site and consolidated for the platform. Metrics, not projections.
- Acceptance discipline
No site is complete until its tests pass.
Every site closes on its written acceptance tests. Tranches release on signed sign-off, not on elapsed time.
Your operating partner and your counsel can read the same documents your sites are built from.
Nothing on this page requires a call to verify. The specification, the library, and the boundaries are published.
- The public diligence room — open now, no form, no call.
- The Build Specification — 28 deliverables, 8 workstreams, an acceptance test per line.
- The 233-file operations library — the documents each site is run from.
We publish no earnings, EBITDA, valuation, or exit projections. Your deal model runs on your inputs, and we pressure-test the operating assumptions with your team.
Who this is for, and what it is not.
This is built for
- Multi-site operators or platform investors adding or scaling a metabolic line
- Decision authority on capex and licensing
- An operating team that will run the sites
This is not
- A franchise
- A passive investment
- A research-product store
- A promise of results
SCHEDULE MASTER TERM SHEET REVIEW
Forty-five minutes with George Tippetts and your development lead: the master agreement draft, the delivery schedule, and your questions — bring counsel.
If the scheduler does not load in your environment, the button above opens it directly. Or write to george@atlasmetabolic.com with two windows.
Before the review
Is this a franchise?
No. There are no royalties, no operational control, and no trademark licence over your brands; each site operates under its own brand. The master agreement is drafted against those elements, and counsel on both sides reviews it before signature.
How are the fifty sites sequenced?
By a written delivery schedule in the master agreement. Buildouts run site by site; each site is acceptance-tested and signed off before the next tranche releases. Market allocation follows the same schedule, and no exclusivity is implied beyond what the agreement states.
Who owns what?
Each operating entity owns its brand, site, patient list, and equity. The platform owns the consolidated commercial assets — the reporting layer, the replication system as configured for the platform, and the master agreement itself. Atlas takes no percentage of revenue and holds no equity at either level. The ownership schedule sets this out in writing.
What about clinical services?
Atlas provides no medical services and employs no clinicians. Any medically supervised care sits with separately licensed medical entities under their own governance. Atlas builds the commercial business around them, and each site's compliance scope is written to that boundary.
Do you publish projections?
No, on principle. Atlas publishes no earnings, EBITDA, valuation, or exit projections. Your deal model runs on your inputs; we pressure-test the operating assumptions with your team, in writing.
Atlas Metabolic builds and licenses business systems to independent operators and platforms. Atlas is not a franchisor. Master License terms are set out in the master agreement and its schedules.